NEUBERGER BERMAN GROUP LLC

Position in GKOS — GLAUKOS Corp

CIK 1465109 NEW YORK, NY

Position in GKOS

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$15,922,267

+$9,850,194 QoQ

Shares Held

147,894

+175.0% QoQ

Ownership

0.252%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 90.13955941417503.ToString("F0")% Shared 0.ToString("F0")% None 9.860440585824982.ToString("F0")%

Healthcare · as of Mar 31, 2026

NEUBERGER BERMAN GROUP LLC holds $2,089,986,282 across 38 Medical Devices names. GKOS ranks #15 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BSX	Boston Scientific Corp	7,072,894	$443,824,098
2	MDT	Medtronic plc	3,698,203	$320,449,289
3	ABT	Abbott Laboratories	2,878,726	$295,558,797
4	HAE	Haemonetics Corp	3,560,918	$200,693,338
5	EW	Edwards Lifesciences Corp	2,350,179	$188,202,334
6	DXCM	Dexcom Inc	1,729,163	$108,591,436
7	PEN	Penumbra Inc	303,621	$99,700,027
8	SYK	Stryker Corp	230,564	$75,761,024

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$15,922,267	147,894	+175.0%	Shares	Defined	2026-05-14
2025-12-31	$6,072,073	53,778	+5.9%	Shares	Defined	2026-02-13
2025-09-30	$4,142,821	50,801	+21.5%	Shares	Defined	2025-11-12
2025-06-30	$4,318,554	41,810	+34.4%	Shares	Defined	2025-08-25
2025-03-31	$3,062,140	31,113	-45.9%	Shares	Defined	2025-05-13
2024-12-31	$8,615,251	57,458	-1.3%	Shares	Defined	2025-02-13
2024-09-30	$7,583,207	58,207	+23.6%	Shares	Defined	2024-11-14
2024-06-30	$5,571,562	47,077	-12.5%	Shares	Defined	2024-11-14
2024-03-31	$5,075,818	53,832	-9.1%	Shares	Defined	2024-11-14
2023-12-31	$4,707,238	59,218	+29.4%	Shares	Defined	2024-11-14
2023-09-30	$3,442,612	45,749	+0.7%	Shares	Defined	2023-11-14
2023-06-30	$3,234,143	45,417	—	Shares	Defined	2023-08-11
No filing history on record for this holder in this stock.